Wet AMD - FOI Response Register

FoI Number
2024-410
Subject
Wet AMD
Date Received
17/10/2024
Request and Response
  1. In the last 12 months of data that you have available, how many patients were treated for wet AMD (wet age-related macular degeneration) (ICD-10 Code H35.30) with the following agents:

A) Bevacizumab- None

B) Faricimab- 39

C) Ranibizumab- None

D) Aflibercept- 310

  1. If possible to answer, in the last 12 months of data that you have available, how many other ophthalmology patients have you treated with the following agents (please list how many for each agent separately):

A) Bevacizumab- None

B) Faricimab- 23

C) Ranibizumab- 8

D) Aflibercept- 141